Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and l-dopa toxicity

► Mitochondria dysfunction-oxidative stress-apoptosis have a role in PD pathogenesis. ► α-Lipoic acid provided early neuroprotection by intervention of this pathogenesis. ► l-Dopa was found to deteriorate PD pathogenesis despite symptomatic motor relief. ► α-Lipoic acid efficiently halted the delete...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Neuroscience research Ročník 71; číslo 4; s. 387 - 395
Hlavní autori: Abdin, Amany A., Sarhan, Naglaa I.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Ireland Elsevier Ireland Ltd 01.12.2011
Predmet:
Animals
Antiparkinson Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Disease Models, Animal
l-Dopa
Levodopa - pharmacology
Mitochondria - drug effects
Mitochondrial dysfunction
Neurons - drug effects
Neurons - ultrastructure
Neuroprotective Agents - pharmacology
Oxidative stress
Oxidative Stress - drug effects
Parkinson Disease - pathology
Parkinson's disease
Rats
Rotenone - toxicity
Thioctic Acid - pharmacology
Uncoupling Agents - toxicity
α-Lipoic acid
α-Lipoic acid
Oxidative stress
Parkinson's disease
Mitochondrial dysfunction
l-Dopa
Apoptosis
ISSN:0168-0102, 1872-8111, 1872-8111
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract ► Mitochondria dysfunction-oxidative stress-apoptosis have a role in PD pathogenesis. ► α-Lipoic acid provided early neuroprotection by intervention of this pathogenesis. ► l-Dopa was found to deteriorate PD pathogenesis despite symptomatic motor relief. ► α-Lipoic acid efficiently halted the deleterious effects of l-dopa. ► α-Lipoic acid recommended as a disease-modifying therapy with l-dopa in early PD. The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of dopaminergic neurons in Parkinson's disease. Model of rotenone-induced parkinsonism in rats produced decrease in striatal complex I activity and reduced glutathione with increase in nitrites concentration and caspase-3 activity. This was confirmed by significant correlation of catalepsy score with neurochemical parameters. Moreover, electron microscopic examination of striatal neurons displayed ultrastructure affection as hyperchromatic nuclei and disrupted mitochondria that are typical features of undergoing apoptosis. Administration of l-dopa as replacement therapy, although caused symptomatic improvement in catalepsy score, but further worsening in neurochemical parameters. Therefore, efforts are not only to improve effect of l-dopa, but also to introduce drugs provide antiparkinsonian and neuroprotective effects. In this study, α-lipoic acid exhibited noticeable neuroprotective effects by a mechanism via intervention of mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways. Combination of α-lipoic acid efficiently halting deleterious toxic effects of l-dopa, revealed normalization of catalepsy score in addition to amelioration of neurochemical parameters and apparent preservation of striatal ultrastructure integrity, indicating benefit of both symptomatic and neuroprotective therapy. In conclusion, α-lipoic acid could be recommended as a disease-modifying therapy when given with l-dopa early in course of Parkinson's disease.
AbstractList The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of dopaminergic neurons in Parkinson's disease. Model of rotenone-induced parkinsonism in rats produced decrease in striatal complex I activity and reduced glutathione with increase in nitrites concentration and caspase-3 activity. This was confirmed by significant correlation of catalepsy score with neurochemical parameters. Moreover, electron microscopic examination of striatal neurons displayed ultrastructure affection as hyperchromatic nuclei and disrupted mitochondria that are typical features of undergoing apoptosis. Administration of L-dopa as replacement therapy, although caused symptomatic improvement in catalepsy score, but further worsening in neurochemical parameters. Therefore, efforts are not only to improve effect of L-dopa, but also to introduce drugs provide antiparkinsonian and neuroprotective effects. In this study, α-lipoic acid exhibited noticeable neuroprotective effects by a mechanism via intervention of mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways. Combination of α-lipoic acid efficiently halting deleterious toxic effects of L-dopa, revealed normalization of catalepsy score in addition to amelioration of neurochemical parameters and apparent preservation of striatal ultrastructure integrity, indicating benefit of both symptomatic and neuroprotective therapy. In conclusion, α-lipoic acid could be recommended as a disease-modifying therapy when given with L-dopa early in course of Parkinson's disease.The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of dopaminergic neurons in Parkinson's disease. Model of rotenone-induced parkinsonism in rats produced decrease in striatal complex I activity and reduced glutathione with increase in nitrites concentration and caspase-3 activity. This was confirmed by significant correlation of catalepsy score with neurochemical parameters. Moreover, electron microscopic examination of striatal neurons displayed ultrastructure affection as hyperchromatic nuclei and disrupted mitochondria that are typical features of undergoing apoptosis. Administration of L-dopa as replacement therapy, although caused symptomatic improvement in catalepsy score, but further worsening in neurochemical parameters. Therefore, efforts are not only to improve effect of L-dopa, but also to introduce drugs provide antiparkinsonian and neuroprotective effects. In this study, α-lipoic acid exhibited noticeable neuroprotective effects by a mechanism via intervention of mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways. Combination of α-lipoic acid efficiently halting deleterious toxic effects of L-dopa, revealed normalization of catalepsy score in addition to amelioration of neurochemical parameters and apparent preservation of striatal ultrastructure integrity, indicating benefit of both symptomatic and neuroprotective therapy. In conclusion, α-lipoic acid could be recommended as a disease-modifying therapy when given with L-dopa early in course of Parkinson's disease.
► Mitochondria dysfunction-oxidative stress-apoptosis have a role in PD pathogenesis. ► α-Lipoic acid provided early neuroprotection by intervention of this pathogenesis. ► l-Dopa was found to deteriorate PD pathogenesis despite symptomatic motor relief. ► α-Lipoic acid efficiently halted the deleterious effects of l-dopa. ► α-Lipoic acid recommended as a disease-modifying therapy with l-dopa in early PD. The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of dopaminergic neurons in Parkinson's disease. Model of rotenone-induced parkinsonism in rats produced decrease in striatal complex I activity and reduced glutathione with increase in nitrites concentration and caspase-3 activity. This was confirmed by significant correlation of catalepsy score with neurochemical parameters. Moreover, electron microscopic examination of striatal neurons displayed ultrastructure affection as hyperchromatic nuclei and disrupted mitochondria that are typical features of undergoing apoptosis. Administration of l-dopa as replacement therapy, although caused symptomatic improvement in catalepsy score, but further worsening in neurochemical parameters. Therefore, efforts are not only to improve effect of l-dopa, but also to introduce drugs provide antiparkinsonian and neuroprotective effects. In this study, α-lipoic acid exhibited noticeable neuroprotective effects by a mechanism via intervention of mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways. Combination of α-lipoic acid efficiently halting deleterious toxic effects of l-dopa, revealed normalization of catalepsy score in addition to amelioration of neurochemical parameters and apparent preservation of striatal ultrastructure integrity, indicating benefit of both symptomatic and neuroprotective therapy. In conclusion, α-lipoic acid could be recommended as a disease-modifying therapy when given with l-dopa early in course of Parkinson's disease.
The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of dopaminergic neurons in Parkinson's disease. Model of rotenone-induced parkinsonism in rats produced decrease in striatal complex I activity and reduced glutathione with increase in nitrites concentration and caspase-3 activity. This was confirmed by significant correlation of catalepsy score with neurochemical parameters. Moreover, electron microscopic examination of striatal neurons displayed ultrastructure affection as hyperchromatic nuclei and disrupted mitochondria that are typical features of undergoing apoptosis. Administration of L-dopa as replacement therapy, although caused symptomatic improvement in catalepsy score, but further worsening in neurochemical parameters. Therefore, efforts are not only to improve effect of L-dopa, but also to introduce drugs provide antiparkinsonian and neuroprotective effects. In this study, α-lipoic acid exhibited noticeable neuroprotective effects by a mechanism via intervention of mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways. Combination of α-lipoic acid efficiently halting deleterious toxic effects of L-dopa, revealed normalization of catalepsy score in addition to amelioration of neurochemical parameters and apparent preservation of striatal ultrastructure integrity, indicating benefit of both symptomatic and neuroprotective therapy. In conclusion, α-lipoic acid could be recommended as a disease-modifying therapy when given with L-dopa early in course of Parkinson's disease.
Author Abdin, Amany A.
Sarhan, Naglaa I.
Author_xml – sequence: 1
  givenname: Amany A.
  surname: Abdin
  fullname: Abdin, Amany A.
  email: amanyabdin@med.tanta.edu.eg, amanynhr@hotmail.com
  organization: Department of Pharmacology, Faculty of Medicine, Tanta University, Egypt
– sequence: 2
  givenname: Naglaa I.
  surname: Sarhan
  fullname: Sarhan, Naglaa I.
  organization: Department of Histology, Faculty of Medicine, Tanta University, Egypt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21889550$$D View this record in MEDLINE/PubMed
BookMark eNqFkctu1DAUhi1URKeFN0DIO1YJviQZhwUSqrhUqsQG1pbHPqFnSOxgOyPmsXgFHoBnwukUFixAsuTF-f5z-f8LcuaDB0KeclZzxrsX-9rDEiHVgnFeM1Uzph6QDVdbUSnO-RnZFExVjDNxTi5S2jPGZN_IR-RccKX6tmUb8uPaZ4gH8BmDp2GgE-Zgb4N3Ec1I3TENi7drsQrf0JmMB6Apl7mpcjCDd0VKzRzmHBImasqjc0gJdyPQdcMwx5DB3gknsLfGY5rWST-_VyPOAS01Fh01nw36lOlKr6dW6N1iwdHZxC-lEu50xjs6Vi7MhuaykMV8fEweDmZM8OT-vySf3r75ePW-uvnw7vrq9U1lpWpzZURnZSd3FkTLGz6YhnV9PwyCgTJuZ7uuV4aBkL0STavEYLZDAZtWWClBOXlJnp_6loO-LpCynjBZGEfjISxJ90x027aVrJDP7sllN4HTc8TJxKP-bXsBmhNgY7EqwvAH4Uyv6eq9PqWr13Q1U7qkW2Qv_5KV-80aTo4Gx_-JX53EUDw6IESdLIIvDmMs8WgX8N8NfgFg1MpL
CitedBy_id crossref_primary_10_1007_s11011_014_9491_x
crossref_primary_10_3390_biom14030273
crossref_primary_10_1016_j_redox_2015_10_006
crossref_primary_10_1016_j_biopha_2022_113330
crossref_primary_10_1155_2020_2360872
crossref_primary_10_1007_s12035_016_0028_7
crossref_primary_10_1016_j_brainres_2013_01_054
crossref_primary_10_1016_j_neuint_2016_10_011
crossref_primary_10_3389_fnins_2020_00612
crossref_primary_10_1007_s12035_013_8517_4
crossref_primary_10_1016_j_neuint_2013_01_007
crossref_primary_10_3390_antiox9070597
crossref_primary_10_1155_2015_408927
crossref_primary_10_3390_ijms160920704
crossref_primary_10_1007_s11055_019_00762_8
crossref_primary_10_1016_j_bbr_2014_08_014
crossref_primary_10_1017_S2040174416000246
crossref_primary_10_1016_j_pbb_2014_03_028
crossref_primary_10_1016_j_lfs_2022_121049
crossref_primary_10_1155_2017_9703574
crossref_primary_10_1155_2013_571378
crossref_primary_10_1016_j_mito_2022_05_001
crossref_primary_10_1080_02648725_2022_2122296
crossref_primary_10_1164_rccm_201304_0691OC
crossref_primary_10_1016_j_mito_2024_101971
crossref_primary_10_1016_j_biopha_2020_110473
crossref_primary_10_1007_s12640_019_9998_3
crossref_primary_10_1111_j_1440_169X_2012_01356_x
crossref_primary_10_1016_j_ejphar_2017_01_042
crossref_primary_10_1002_cbf_3163
crossref_primary_10_33549_physiolres_934095
crossref_primary_10_1007_s10787_017_0331_6
Cites_doi 10.1016/0003-2697(69)90064-5
10.1007/s12264-010-0302-z
10.1016/j.neulet.2006.03.064
10.1007/s11626-008-9164-3
10.1016/S0278-5846(03)00019-8
10.1007/s10495-008-0309-3
10.1046/j.1365-2362.1999.00447.x
10.1016/S0024-3205(98)00275-6
10.1016/j.yrtph.2006.06.004
10.1016/S0021-9258(19)52451-6
10.1038/sj.bjp.0704982
10.1016/j.brainresrev.2007.02.001
10.1038/81834
10.1016/0891-5849(95)00017-R
10.2174/0929867043365387
10.1016/S0166-4328(02)00180-8
10.1016/S0167-4889(00)00078-1
10.1016/S0006-2952(96)00459-5
10.1016/j.bbadis.2009.10.007
10.1096/fj.02-0653fje
10.1016/j.brainres.2005.04.051
10.1002/biof.5520170120
10.1007/s13167-010-0019-0
10.1096/fj.06-7580com
10.1074/jbc.M512203200
10.1016/j.parkreldis.2008.04.026
10.1016/S1353-8020(09)70010-0
10.1016/j.canlet.2004.10.021
10.1016/S0079-6336(03)80002-5
10.1073/pnas.040556597
10.1006/niox.2000.0319
10.1016/j.neures.2004.09.002
10.1523/JNEUROSCI.12-05-01658.1992
10.1007/BF00970754
10.1046/j.1471-4159.2003.01513.x
10.1007/s00702-009-0232-y
10.1016/j.bbadis.2009.08.013
10.1016/j.neuroscience.2007.04.002
10.1016/j.clnu.2005.04.005
10.1006/abio.1997.2220
10.1007/s11064-007-9299-8
10.1006/bmmb.1994.1004
10.1016/j.expneurol.2003.12.005
10.1002/mds.1090
10.1016/S0531-5565(02)00015-3
10.1016/j.bbr.2003.12.021
10.1523/JNEUROSCI.23-34-10756.2003
10.1006/taap.2002.9437
10.1016/j.neuint.2007.02.002
10.1016/S0891-5849(02)01327-8
10.1016/j.bbagen.2009.07.026
10.1111/j.1749-6632.2002.tb02119.x
10.1023/B:NERE.0000014827.94562.4b
10.3109/10715769609088005
10.1523/JNEUROSCI.22-16-07006.2002
10.1002/ana.410360305
10.1007/s00701-010-0703-9
10.1016/j.brainres.2008.01.081
10.1046/j.1471-4159.2003.02067.x
10.3109/03602539808996311
10.1097/00001756-199507310-00004
10.1016/S0891-5849(96)00269-9
10.1007/s11064-008-9656-2
10.1016/j.lfs.2010.03.019
10.1016/j.brainres.2008.11.025
10.1007/s00401-010-0740-8
10.1016/j.tox.2006.02.015
10.1016/S0304-4165(02)00440-3
10.1016/0304-3940(94)90603-3
10.1179/135100001101536472
10.1016/j.febslet.2009.10.016
10.1016/0304-3940(82)90390-1
10.1007/s10495-009-0323-0
10.1046/j.1471-4159.1996.67062282.x
10.1007/s10495-005-1901-4
ContentType Journal Article
Copyright 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society
Copyright © 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
Copyright_xml – notice: 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society
– notice: Copyright © 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.neures.2011.08.008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1872-8111
EndPage 395
ExternalDocumentID 21889550
10_1016_j_neures_2011_08_008
S016801021102061X
Genre Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
0SF
123
1B1
1RT
1~.
1~5
29N
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AADPK
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
ABCQJ
ABFNM
ABFRF
ABIVO
ABJNI
ABMAC
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMQ
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M2V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SNS
SPCBC
SSN
SSZ
T5K
UNMZH
WUQ
ZGI
~G-
9DU
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACLOT
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEIPS
AEUPX
AFJKZ
AFPUW
AGQPQ
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
EFKBS
GROUPED_DOAJ
~HD
AGCQF
AGRNS
BNPGV
CGR
CUY
CVF
ECM
EIF
NPM
SSH
7X8
ID FETCH-LOGICAL-c385t-a26c363bce25141fa40699ff20e8adbc6698a0e239824582fa7f514452c33e8d3
ISICitedReferencesCount 37
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000297877000010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0168-0102
1872-8111
IngestDate Sun Nov 09 09:12:10 EST 2025
Mon Jul 21 06:03:13 EDT 2025
Tue Nov 18 21:49:46 EST 2025
Sat Nov 29 06:47:02 EST 2025
Fri Feb 23 02:26:44 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords α-Lipoic acid
Oxidative stress
Parkinson's disease
Mitochondrial dysfunction
l-Dopa
Apoptosis
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c385t-a26c363bce25141fa40699ff20e8adbc6698a0e239824582fa7f514452c33e8d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21889550
PQID 902675530
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_902675530
pubmed_primary_21889550
crossref_primary_10_1016_j_neures_2011_08_008
crossref_citationtrail_10_1016_j_neures_2011_08_008
elsevier_sciencedirect_doi_10_1016_j_neures_2011_08_008
PublicationCentury 2000
PublicationDate 2011-12-01
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: 2011-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Neuroscience research
PublicationTitleAlternate Neurosci Res
PublicationYear 2011
Publisher Elsevier Ireland Ltd
Publisher_xml – name: Elsevier Ireland Ltd
References Schmidt, Alam (bib0290) 2006; 70
Spencer, Jenner, Halliwell (bib0340) 1995; 6
Kashihara, Sakai, Marui, Shohmori (bib0160) 1996; 63
Birch-Machin, Briggs, Saborido, Bindoff, Turnbull (bib0050) 1994; 51
Miller, James-Kracke, Sun, Sun (bib0195) 2009; 34
Kiernan (bib0165) 1981
Naydenov, Vassoler, Luksik, Kaczmarska, Konradi (bib0220) 2010; 120
Prahalathan, Selvakumar, Varalakshmi, Kumarasamy, Saravanan (bib0270) 2006; 222
Persson, Svensson, Brunk (bib0265) 2001; 6
Hartmann, Hunot, Michel, Muriel, Vyas, Faucheux, Mouatt-Prigent, Turmel, Srinivasan, Ruberg, Evan, Agid, Hirsch (bib0140) 2000; 97
Pedrosa, Soares-da-Silva (bib0250) 2002; 137
Savitha, Sivarajan, Haripriya, Kokilavani, Panneerselvam (bib0285) 2005; 24
Moini, Packer, Saris (bib0205) 2002; 182
Bashkatova, Alam, Vanin, Schmidt (bib0030) 2004; 186
Tietze (bib0365) 1969; 27
Banerjee, Sreetama, Saravanan, Dey, Mohanakumar (bib0025) 2007; 32
Marsh, Pat, Gobe, Coombes (bib0190) 2005; 10
Thaakur, Himabindhu (bib0360) 2009; 116
Bozzola, Russel (bib0060) 1999
Gurtu, Kain, Zhang (bib0120) 1997; 251
Pei, Liou, Chenm (bib0255) 2003; 17
Spencer, Jenner, Butler, Aruoma, Dexter, Jenner, Halliwell (bib0335) 1996; 24
Yamasaki, Kawabe, Nishimoto, Madhyastha, Sakakibara, Suiko, Okamoto, Suda, Uehira, Nishiyama (bib0395) 2009; 45
Sian, Dexter, Lees, Daniel, Agid, Javoy-Agid, Jenner, Marsden (bib0315) 1994; 36
Cadenas, Packer (bib0070) 1996
Bilska, Dubiel, Sokołowska-Jezewicz, Lorenc-Koci, Włodek (bib0045) 2007; 146
Levy, Malagelada, Greene (bib0175) 2009; 14
Tasker, Adams-Marriott, Shaw (bib0355) 2010; 1
Turpeenoja, Villa, Magri, Stella (bib0375) 1988; 13
Dahm, Moore, Murphy (bib0090) 2006; 281
Dudman, Eaton, Rajadhyaksha, Macías, Taher, Barczak, Kameyama, Huganir, Konradi (bib0095) 2003; 87
Emmez, Yildirim, Kale, Tönge, Durdağ, Börcek, Uçankuş, Doğulu, Kiliç, Baykaner (bib0105) 2010; 152
Otsuki, Li, Shibata (bib0230) 2003; 38
Przedborski, Jackson-Lewis, Yokoyama, Shibata, Dawson, Dawson (bib0275) 1996; 12
Tanaka, Ogawa (bib0350) 2005; 51
Moreira, Zhu, Wang, Lee, Nunomura, Petersen, Perry, Smith (bib0210) 2010; 1802
Sherer, Betarbet, Testa, Seo, Richardson, Kim, Miller, Yagi, Matsuno-Yagi, Greenamyre (bib0310) 2003; 23
Gogvadze, Orrenius, Zhivotovsky (bib0115) 2009; 14
Cremer, Rabeler, Roberts, Lynch (bib0085) 2006; 46
Itokawa, Ohkuma, Araki, Tamura, Shimazu (bib0150) 2006; 402
Bast, Haenen (bib0035) 2003; 17
Hattoria, Wanga, Taka, Fujimura, Yoritaka, Kubo, Mochizuki (bib0145) 2009; 15
Alam, Schmidt (bib0010) 2002; 136
Fujita, Shiosaka, Ogino, Okimura, Utsumi, Sato, Akagi, Inoue, Utsumi, Sasaki (bib0110) 2008; 1206
Miranda, Espey, Wink (bib0200) 2001; 5
Wei, Chen, Hou, Xin, Mori (bib0385) 2000; 1498
Winklhofer, Haass (bib0390) 2010; 1802
Alam, Schmidt (bib0015) 2004; 153
Budd, Nicholls (bib0065) 1996; 67
Singh, Dikshit (bib0320) 2007; 54
Packer, Witt, Tritschler (bib0245) 1995; 19
Stewart, Heales (bib0345) 2003; 34
Arivazhagan, Shila, Kumaran, Panneerselvam (bib0020) 2002; 37
Lev, Melamed, Offen (bib0170) 2003; 27
Bitar, Ayed, Abdel-Halim, Isenovic, Al-Mulla (bib0055) 2010; 86
Perry, Godin, Hansen (bib0260) 1982; 33
Saravanan, Sindhu, Mohanakumar (bib0280) 2005; 1049
Sipos, Tretter, Adam-Vizi (bib0325) 2003; 84
Lowry, Rosebrough, Farr, Randall (bib0185) 1951; 193
Packer (bib0235) 1998; 30
Vila, Perier (bib0380) 2008; 14
Ahlskog, Muenter (bib0005) 2001; 16
Betarbet, Sherer, MacKenzie, Garcia-Osuna, Panov, Greenamyre (bib0040) 2000; 3
Hagen, Moreau, Suh, Visioli (bib0125) 2002; 959
Chng, New, Neo, Goh, Browne, Chan (bib0080) 2009; 1251
Han, Handelman, Marcocci, Sen, Roy, Kobuchi, Tritschler, Flohé, Packer (bib0135) 1997; 9
Chalimoniuk, Langfort (bib0075) 2007; 50
Schweizer, Richter (bib0295) 1996; 52
Emdadul Haque, Asanuma, Higashi, Miyazaki, Tanaka, Ogawa (bib0100) 2003; 1619
Li, Wogan (bib0180) 2005; 226
Packer, Tritschler, Wessel (bib0240) 1997; 22
Shay, Moreau, Smith, Smith, Hagen (bib0305) 2009; 1790
Sengupta, Billiar, Atkins, Kagan, Stoyanovsky (bib0300) 2009; 583
Smith, Shenvi, Widlansky, Suh, Hagen (bib0330) 2004; 11
Karunakaran, Diwakar, Saeed, Agarwal, Ramakrishnan, Iyengar, Ravindranath (bib0155) 2007; 21
Yuan, Zhang, Liang, Shen, Wang, Ren, Ma, Jiao, Liu (bib0400) 2010; 26
Ogawa, Asanuma, Kondo, Kawada, Yamamoto, Mori (bib0225) 1994; 17
Sherer, Betarbet, Stout, Lund, Baptista, Panov, Cookson, Greenamyre (bib0405) 2002; 22
Tretter, Sipos, Adam-Vizi (bib0370) 2004; 29
Hall (bib0130) 1999; 29
Hattoria (10.1016/j.neures.2011.08.008_bib0145) 2009; 15
Singh (10.1016/j.neures.2011.08.008_bib0320) 2007; 54
Chalimoniuk (10.1016/j.neures.2011.08.008_bib0075) 2007; 50
Shay (10.1016/j.neures.2011.08.008_bib0305) 2009; 1790
Bitar (10.1016/j.neures.2011.08.008_bib0055) 2010; 86
Levy (10.1016/j.neures.2011.08.008_bib0175) 2009; 14
Gogvadze (10.1016/j.neures.2011.08.008_bib0115) 2009; 14
Ahlskog (10.1016/j.neures.2011.08.008_bib0005) 2001; 16
Alam (10.1016/j.neures.2011.08.008_bib0015) 2004; 153
Chng (10.1016/j.neures.2011.08.008_bib0080) 2009; 1251
Arivazhagan (10.1016/j.neures.2011.08.008_bib0020) 2002; 37
Saravanan (10.1016/j.neures.2011.08.008_bib0280) 2005; 1049
Bashkatova (10.1016/j.neures.2011.08.008_bib0030) 2004; 186
Betarbet (10.1016/j.neures.2011.08.008_bib0040) 2000; 3
Spencer (10.1016/j.neures.2011.08.008_bib0340) 1995; 6
Wei (10.1016/j.neures.2011.08.008_bib0385) 2000; 1498
Birch-Machin (10.1016/j.neures.2011.08.008_bib0050) 1994; 51
Hagen (10.1016/j.neures.2011.08.008_bib0125) 2002; 959
Dahm (10.1016/j.neures.2011.08.008_bib0090) 2006; 281
Sipos (10.1016/j.neures.2011.08.008_bib0325) 2003; 84
Itokawa (10.1016/j.neures.2011.08.008_bib0150) 2006; 402
Karunakaran (10.1016/j.neures.2011.08.008_bib0155) 2007; 21
Schweizer (10.1016/j.neures.2011.08.008_bib0295) 1996; 52
Fujita (10.1016/j.neures.2011.08.008_bib0110) 2008; 1206
Han (10.1016/j.neures.2011.08.008_bib0135) 1997; 9
Dudman (10.1016/j.neures.2011.08.008_bib0095) 2003; 87
Persson (10.1016/j.neures.2011.08.008_bib0265) 2001; 6
Spencer (10.1016/j.neures.2011.08.008_bib0335) 1996; 24
Sian (10.1016/j.neures.2011.08.008_bib0315) 1994; 36
Cadenas (10.1016/j.neures.2011.08.008_bib0070) 1996
Stewart (10.1016/j.neures.2011.08.008_bib0345) 2003; 34
Yuan (10.1016/j.neures.2011.08.008_bib0400) 2010; 26
Li (10.1016/j.neures.2011.08.008_bib0180) 2005; 226
Marsh (10.1016/j.neures.2011.08.008_bib0190) 2005; 10
Otsuki (10.1016/j.neures.2011.08.008_bib0230) 2003; 38
Moreira (10.1016/j.neures.2011.08.008_bib0210) 2010; 1802
Perry (10.1016/j.neures.2011.08.008_bib0260) 1982; 33
Sherer (10.1016/j.neures.2011.08.008_bib0310) 2003; 23
Naydenov (10.1016/j.neures.2011.08.008_bib0220) 2010; 120
Przedborski (10.1016/j.neures.2011.08.008_bib0275) 1996; 12
Bilska (10.1016/j.neures.2011.08.008_bib0045) 2007; 146
Tasker (10.1016/j.neures.2011.08.008_bib0355) 2010; 1
Tietze (10.1016/j.neures.2011.08.008_bib0365) 1969; 27
Moini (10.1016/j.neures.2011.08.008_bib0205) 2002; 182
Packer (10.1016/j.neures.2011.08.008_bib0235) 1998; 30
Kashihara (10.1016/j.neures.2011.08.008_bib0160) 1996; 63
Budd (10.1016/j.neures.2011.08.008_bib0065) 1996; 67
Yamasaki (10.1016/j.neures.2011.08.008_bib0395) 2009; 45
Banerjee (10.1016/j.neures.2011.08.008_bib0025) 2007; 32
Vila (10.1016/j.neures.2011.08.008_bib0380) 2008; 14
Miller (10.1016/j.neures.2011.08.008_bib0195) 2009; 34
Turpeenoja (10.1016/j.neures.2011.08.008_bib0375) 1988; 13
Kiernan (10.1016/j.neures.2011.08.008_bib0165) 1981
Savitha (10.1016/j.neures.2011.08.008_bib0285) 2005; 24
Bast (10.1016/j.neures.2011.08.008_bib0035) 2003; 17
Hartmann (10.1016/j.neures.2011.08.008_bib0140) 2000; 97
Miranda (10.1016/j.neures.2011.08.008_bib0200) 2001; 5
Sherer (10.1016/j.neures.2011.08.008_bib0405) 2002; 22
Smith (10.1016/j.neures.2011.08.008_bib0330) 2004; 11
Winklhofer (10.1016/j.neures.2011.08.008_bib0390) 2010; 1802
Bozzola (10.1016/j.neures.2011.08.008_bib0060) 1999
Lev (10.1016/j.neures.2011.08.008_bib0170) 2003; 27
Emdadul Haque (10.1016/j.neures.2011.08.008_bib0100) 2003; 1619
Emmez (10.1016/j.neures.2011.08.008_bib0105) 2010; 152
Tretter (10.1016/j.neures.2011.08.008_bib0370) 2004; 29
Ogawa (10.1016/j.neures.2011.08.008_bib0225) 1994; 17
Packer (10.1016/j.neures.2011.08.008_bib0240) 1997; 22
Packer (10.1016/j.neures.2011.08.008_bib0245) 1995; 19
Prahalathan (10.1016/j.neures.2011.08.008_bib0270) 2006; 222
Thaakur (10.1016/j.neures.2011.08.008_bib0360) 2009; 116
Gurtu (10.1016/j.neures.2011.08.008_bib0120) 1997; 251
Cremer (10.1016/j.neures.2011.08.008_bib0085) 2006; 46
Schmidt (10.1016/j.neures.2011.08.008_bib0290) 2006; 70
Sengupta (10.1016/j.neures.2011.08.008_bib0300) 2009; 583
Pedrosa (10.1016/j.neures.2011.08.008_bib0250) 2002; 137
Alam (10.1016/j.neures.2011.08.008_bib0010) 2002; 136
Lowry (10.1016/j.neures.2011.08.008_bib0185) 1951; 193
Pei (10.1016/j.neures.2011.08.008_bib0255) 2003; 17
Hall (10.1016/j.neures.2011.08.008_bib0130) 1999; 29
Tanaka (10.1016/j.neures.2011.08.008_bib0350) 2005; 51
References_xml – volume: 51
  start-page: 35
  year: 1994
  end-page: 42
  ident: bib0050
  article-title: An evaluation of the measurement of the activities of complexes I–IV in the respiratory chain of human skeletal muscle mitochondria
  publication-title: Biochem. Med. Metab. Biol.
– volume: 222
  start-page: 225
  year: 2006
  end-page: 232
  ident: bib0270
  article-title: Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells
  publication-title: Toxicology
– volume: 46
  start-page: 29
  year: 2006
  end-page: 41
  ident: bib0085
  article-title: Safety evaluation of alpha-lipoic acid (ALA)
  publication-title: Regul. Toxicol. Pharmacol.
– volume: 63
  start-page: PL59
  year: 1996
  end-page: PL64
  ident: bib0160
  publication-title: Life Sci.
– volume: 116
  start-page: 807
  year: 2009
  end-page: 814
  ident: bib0360
  article-title: Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats
  publication-title: J. Neural Transm.
– volume: 1049
  start-page: 147
  year: 2005
  end-page: 155
  ident: bib0280
  article-title: Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease
  publication-title: Brain Res.
– volume: 33
  start-page: 305
  year: 1982
  end-page: 310
  ident: bib0260
  article-title: Parkinson's disease: a disorder due to nigral glutathione deficiency?
  publication-title: Neurosci. Lett
– volume: 6
  start-page: 1480
  year: 1995
  end-page: 1484
  ident: bib0340
  article-title: Superoxide-dependent depletion of reduced glutathione by
  publication-title: Neuroreport
– volume: 1206
  start-page: 1
  year: 2008
  end-page: 12
  ident: bib0110
  article-title: Alpha-lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1
  publication-title: Brain Res.
– volume: 12
  start-page: 1658
  year: 1996
  end-page: 1667
  ident: bib0275
  article-title: Role of nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrapyridine (MPTP)-induced dopaminergic neurotoxicity
  publication-title: J. Neurosci.
– volume: 146
  start-page: 1758
  year: 2007
  end-page: 1771
  ident: bib0045
  article-title: Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain
  publication-title: Neuroscience
– volume: 34
  start-page: 55
  year: 2009
  end-page: 65
  ident: bib0195
  article-title: Oxidative and inflammatory pathways in Parkinson's disease
  publication-title: Neurochem. Res.
– volume: 32
  start-page: 1238
  year: 2007
  end-page: 1247
  ident: bib0025
  article-title: Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague–Dawley rats: cellular, molecular and ultrastructural evidences
  publication-title: Neurochem. Res.
– volume: 120
  start-page: 623
  year: 2010
  end-page: 631
  ident: bib0220
  article-title: Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia
  publication-title: Acta Neuropathol.
– volume: 22
  start-page: 7006
  year: 2002
  end-page: 7015
  ident: bib0405
  article-title: An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered-synuclein metabolism and oxidative damage
  publication-title: J. Neurosci.
– volume: 29
  start-page: 569
  year: 2004
  end-page: 577
  ident: bib0370
  article-title: Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease
  publication-title: Neurochem. Res.
– volume: 50
  start-page: 821
  year: 2007
  end-page: 833
  ident: bib0075
  article-title: The effect of subchronic, intermittent
  publication-title: Neurochem. Int.
– volume: 67
  start-page: 2282
  year: 1996
  end-page: 2291
  ident: bib0065
  article-title: Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells
  publication-title: J. Neurochem.
– volume: 15
  start-page: S35
  year: 2009
  end-page: S38
  ident: bib0145
  article-title: Toxic effects of dopamine metabolism in Parkinson's disease
  publication-title: Parkinsonism Relat. Disord.
– volume: 583
  start-page: 3525
  year: 2009
  end-page: 3530
  ident: bib0300
  article-title: Nitric oxide and dihydrolipoic acid modulate the activity of caspase 3 in HepG2 cells
  publication-title: FEBS Lett.
– volume: 27
  start-page: 502
  year: 1969
  end-page: 522
  ident: bib0365
  article-title: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues
  publication-title: Anal. Biochem.
– volume: 13
  start-page: 859
  year: 1988
  end-page: 865
  ident: bib0375
  article-title: Changes of mitochondrial membrane proteins in rat cerebellum during aging
  publication-title: Neurochem. Res.
– volume: 153
  start-page: 439
  year: 2004
  end-page: 446
  ident: bib0015
  publication-title: Behav. Brain Res.
– volume: 17
  start-page: 520
  year: 2003
  end-page: 522
  ident: bib0255
  article-title: Two caspase-mediated apoptotic pathways induced by rotenone toxicity in cortical neuronal cells
  publication-title: FASEB J.
– volume: 11
  start-page: 1135
  year: 2004
  end-page: 1146
  ident: bib0330
  article-title: Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress
  publication-title: Curr. Med. Chem.
– volume: 23
  start-page: 10756
  year: 2003
  end-page: 10764
  ident: bib0310
  article-title: Mechanism of toxicity in rotenone models of Parkinson's disease
  publication-title: J. Neurosci.
– volume: 9
  start-page: 1
  year: 1997
  end-page: 18
  ident: bib0135
  article-title: Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization
  publication-title: Biofactors
– volume: 1790
  start-page: 1149
  year: 2009
  end-page: 1160
  ident: bib0305
  article-title: Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential
  publication-title: Biochim. Biophys. Acta
– year: 1981
  ident: bib0165
  article-title: Histological and Histochemical Methods: Theory and Practice
– volume: 17
  start-page: 55
  year: 1994
  end-page: 58
  ident: bib0225
  article-title: Differential effects of chronic
  publication-title: Neurosci. Lett.
– volume: 136
  start-page: 317
  year: 2002
  end-page: 324
  ident: bib0010
  article-title: Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
  publication-title: Behav. Brain Res.
– volume: 3
  start-page: 1301
  year: 2000
  end-page: 1306
  ident: bib0040
  article-title: Chronic systemic pesticide exposure reproduces features of Parkinson's disease
  publication-title: Nat. Neurosci.
– volume: 959
  start-page: 491
  year: 2002
  end-page: 507
  ident: bib0125
  article-title: Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-
  publication-title: Ann. N.Y. Acad. Sci.
– volume: 137
  start-page: 1305
  year: 2002
  end-page: 1313
  ident: bib0250
  article-title: Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by
  publication-title: Br. J. Pharmacol.
– volume: 14
  start-page: 624
  year: 2009
  end-page: 640
  ident: bib0115
  article-title: Mitochondria as targets for chemotherapy
  publication-title: Apoptosis
– year: 1999
  ident: bib0060
  article-title: Electron Microscopy Principles and Techniques for Biologists
– volume: 402
  start-page: 142
  year: 2006
  end-page: 144
  ident: bib0150
  article-title: Effect of l-DOPA on nitric oxide production in striatum of freely mobile mice
  publication-title: Neurosci. Lett.
– volume: 19
  start-page: 227
  year: 1995
  end-page: 250
  ident: bib0245
  article-title: Alpha-lipoic acid as a biological antioxidant
  publication-title: Free Radic. Biol. Med.
– volume: 45
  start-page: 275
  year: 2009
  end-page: 280
  ident: bib0395
  article-title: Dihydro-alpha-lipoic acid has more potent cytotoxicity than alpha-lipoic acid
  publication-title: In Vitro Cell Dev. Biol. Anim.
– volume: 26
  start-page: 66
  year: 2010
  end-page: 76
  ident: bib0400
  article-title: Treatment strategies for Parkinson's disease
  publication-title: Neurosci. Bull.
– volume: 1251
  start-page: 80
  year: 2009
  end-page: 86
  ident: bib0080
  article-title: Distribution study of orally administered lipoic acid in rat brain tissues
  publication-title: Brain Res.
– volume: 29
  start-page: 238
  year: 1999
  end-page: 245
  ident: bib0130
  article-title: The role of glutathione in the regulation of apoptosis
  publication-title: Eur. J. Clin. Invest.
– volume: 14
  start-page: 478
  year: 2009
  end-page: 500
  ident: bib0175
  article-title: Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps
  publication-title: Apoptosis
– volume: 182
  start-page: 84
  year: 2002
  end-page: 90
  ident: bib0205
  article-title: Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 281
  start-page: 10056
  year: 2006
  end-page: 10065
  ident: bib0090
  article-title: Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria
  publication-title: J. Biol. Chem.
– volume: 52
  start-page: 1815
  year: 1996
  end-page: 1820
  ident: bib0295
  article-title: Stimulation of Ca
  publication-title: Biochem. Pharmacol.
– volume: 22
  start-page: 359
  year: 1997
  end-page: 378
  ident: bib0240
  article-title: Neuroprotection by the metabolic antioxidant alpha-lipoic acid
  publication-title: Free Radic. Biol. Med.
– volume: 186
  start-page: 235
  year: 2004
  end-page: 241
  ident: bib0030
  article-title: Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain
  publication-title: Exp. Neurol.
– volume: 1802
  start-page: 212
  year: 2010
  end-page: 220
  ident: bib0210
  article-title: Mitochondria: a therapeutic target in neurodegeneration
  publication-title: Biochim. Biophys. Acta
– volume: 24
  start-page: 794
  year: 2005
  end-page: 800
  ident: bib0285
  article-title: Efficacy of levo carnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging
  publication-title: Clin. Nutr.
– volume: 70
  start-page: 273
  year: 2006
  end-page: 276
  ident: bib0290
  article-title: Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD)
  publication-title: J. Neural Transm. Suppl.
– volume: 10
  start-page: 657
  year: 2005
  end-page: 665
  ident: bib0190
  article-title: Evidence for a non-antioxidant, dose-dependent role of alpha-lipoic acid in caspase-3 and ERK2 activation in endothelial cells
  publication-title: Apoptosis
– volume: 30
  start-page: 245
  year: 1998
  end-page: 275
  ident: bib0235
  article-title: Alpha-lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury
  publication-title: Drug Metab. Rev.
– volume: 54
  start-page: 233
  year: 2007
  end-page: 250
  ident: bib0320
  article-title: Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide
  publication-title: Brain Res. Rev.
– volume: 16
  start-page: 448
  year: 2001
  end-page: 458
  ident: bib0005
  article-title: Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
  publication-title: Mov. Disord.
– volume: 36
  start-page: 348
  year: 1994
  end-page: 355
  ident: bib0315
  article-title: Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
  publication-title: Ann. Neurol.
– volume: 34
  start-page: 287
  year: 2003
  end-page: 303
  ident: bib0345
  article-title: Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration
  publication-title: Free Radic. Biol. Med.
– volume: 51
  start-page: 9
  year: 2005
  end-page: 13
  ident: bib0350
  article-title: Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice
  publication-title: Neurosci. Res.
– volume: 21
  start-page: 2226
  year: 2007
  end-page: 2236
  ident: bib0155
  article-title: Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid
  publication-title: FASEB J.
– volume: 1
  start-page: 217
  year: 2010
  end-page: 227
  ident: bib0355
  article-title: New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment
  publication-title: EPMA J.
– volume: 17
  start-page: 207
  year: 2003
  end-page: 213
  ident: bib0035
  article-title: Lipoic acid: a multifunctional antioxidant
  publication-title: Biofactors
– volume: 14
  start-page: S176
  year: 2008
  end-page: S179
  ident: bib0380
  article-title: Molecular pathways of programmed cell death in experimental Parkinson's disease
  publication-title: Parkinsonism Relat. Disord.
– volume: 84
  start-page: 112
  year: 2003
  end-page: 118
  ident: bib0325
  article-title: Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals
  publication-title: J. Neurochem.
– volume: 1498
  start-page: 72
  year: 2000
  end-page: 79
  ident: bib0385
  article-title: Nitric oxide induces oxidative stress and apoptosis in neuronal cells
  publication-title: Biochim. Biophys. Acta
– volume: 5
  start-page: 62
  year: 2001
  end-page: 71
  ident: bib0200
  article-title: A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite
  publication-title: Nitric Oxide
– volume: 86
  start-page: 844
  year: 2010
  end-page: 853
  ident: bib0055
  article-title: Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism
  publication-title: Life Sci.
– volume: 87
  start-page: 922
  year: 2003
  end-page: 934
  ident: bib0095
  article-title: Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1
  publication-title: J. Neurochem.
– volume: 226
  start-page: 1
  year: 2005
  end-page: 15
  ident: bib0180
  article-title: Nitric oxide as a modulator of apoptosis
  publication-title: Cancer Lett.
– volume: 6
  start-page: 327
  year: 2001
  end-page: 334
  ident: bib0265
  article-title: Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis
  publication-title: Redox Rep.
– volume: 27
  start-page: 245
  year: 2003
  end-page: 250
  ident: bib0170
  article-title: Apoptosis and Parkinson's disease
  publication-title: Prog. Neuropsychopharmacol. Boil. Psychiatry
– volume: 251
  start-page: 98
  year: 1997
  end-page: 102
  ident: bib0120
  article-title: Fluorometric and colorimetric detection of caspase activity associated with apoptosis
  publication-title: Anal. Biochem.
– volume: 152
  start-page: 1591
  year: 2010
  end-page: 1600
  ident: bib0105
  article-title: Anti-apoptotic and neuroprotective effects of alpha-lipoic acid on spinal cord ischemia-reperfusion injury in rabbits
  publication-title: Acta. Neurochir. (Wien)
– volume: 97
  start-page: 2875
  year: 2000
  end-page: 2880
  ident: bib0140
  article-title: Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 38
  start-page: 275
  year: 2003
  end-page: 339
  ident: bib0230
  article-title: Apoptotic detection methods—from morphology to gene
  publication-title: Prog. Histochem. Cytochem.
– volume: 37
  start-page: 803
  year: 2002
  end-page: 811
  ident: bib0020
  article-title: Effect of
  publication-title: Exp. Gerontol.
– volume: 1802
  start-page: 29
  year: 2010
  end-page: 44
  ident: bib0390
  article-title: Mitochondrial dysfunction in Parkinson's disease
  publication-title: Biochim. Biophys. Acta
– volume: 193
  start-page: 265
  year: 1951
  end-page: 275
  ident: bib0185
  article-title: Protein measurement with the Folin-Phenol reagent
  publication-title: J. Biol. Chem.
– volume: 1619
  start-page: 39
  year: 2003
  end-page: 52
  ident: bib0100
  article-title: Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells
  publication-title: Biochim. Biophys. Acta
– volume: 24
  start-page: 95
  year: 1996
  end-page: 105
  ident: bib0335
  article-title: Evaluation of the pro-oxidant and antioxidant actions of
  publication-title: Free Radic. Res.
– year: 1996
  ident: bib0070
  article-title: Handbook of Antioxidants
– volume: 27
  start-page: 502
  year: 1969
  ident: 10.1016/j.neures.2011.08.008_bib0365
  article-title: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues
  publication-title: Anal. Biochem.
  doi: 10.1016/0003-2697(69)90064-5
– volume: 26
  start-page: 66
  issue: 1
  year: 2010
  ident: 10.1016/j.neures.2011.08.008_bib0400
  article-title: Treatment strategies for Parkinson's disease
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-010-0302-z
– volume: 402
  start-page: 142
  year: 2006
  ident: 10.1016/j.neures.2011.08.008_bib0150
  article-title: Effect of l-DOPA on nitric oxide production in striatum of freely mobile mice
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2006.03.064
– volume: 45
  start-page: 275
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0395
  article-title: Dihydro-alpha-lipoic acid has more potent cytotoxicity than alpha-lipoic acid
  publication-title: In Vitro Cell Dev. Biol. Anim.
  doi: 10.1007/s11626-008-9164-3
– volume: 27
  start-page: 245
  issue: 2
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0170
  article-title: Apoptosis and Parkinson's disease
  publication-title: Prog. Neuropsychopharmacol. Boil. Psychiatry
  doi: 10.1016/S0278-5846(03)00019-8
– volume: 14
  start-page: 478
  issue: 4
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0175
  article-title: Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps
  publication-title: Apoptosis
  doi: 10.1007/s10495-008-0309-3
– volume: 29
  start-page: 238
  year: 1999
  ident: 10.1016/j.neures.2011.08.008_bib0130
  article-title: The role of glutathione in the regulation of apoptosis
  publication-title: Eur. J. Clin. Invest.
  doi: 10.1046/j.1365-2362.1999.00447.x
– volume: 63
  start-page: PL59
  issue: 4
  year: 1996
  ident: 10.1016/j.neures.2011.08.008_bib0160
  article-title: l-Dopa does not facilitate nitric oxide production in the rat striatum and substantia nigra: in vivo microdialysis study
  publication-title: Life Sci.
  doi: 10.1016/S0024-3205(98)00275-6
– volume: 46
  start-page: 29
  year: 2006
  ident: 10.1016/j.neures.2011.08.008_bib0085
  article-title: Safety evaluation of alpha-lipoic acid (ALA)
  publication-title: Regul. Toxicol. Pharmacol.
  doi: 10.1016/j.yrtph.2006.06.004
– volume: 193
  start-page: 265
  year: 1951
  ident: 10.1016/j.neures.2011.08.008_bib0185
  article-title: Protein measurement with the Folin-Phenol reagent
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)52451-6
– volume: 137
  start-page: 1305
  issue: 8
  year: 2002
  ident: 10.1016/j.neures.2011.08.008_bib0250
  article-title: Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by l-3,4-dihydroxyphenylalanine (l-DOPA) and dopamine
  publication-title: Br. J. Pharmacol.
  doi: 10.1038/sj.bjp.0704982
– volume: 54
  start-page: 233
  issue: 2
  year: 2007
  ident: 10.1016/j.neures.2011.08.008_bib0320
  article-title: Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide
  publication-title: Brain Res. Rev.
  doi: 10.1016/j.brainresrev.2007.02.001
– volume: 3
  start-page: 1301
  issue: 12
  year: 2000
  ident: 10.1016/j.neures.2011.08.008_bib0040
  article-title: Chronic systemic pesticide exposure reproduces features of Parkinson's disease
  publication-title: Nat. Neurosci.
  doi: 10.1038/81834
– volume: 19
  start-page: 227
  issue: 2
  year: 1995
  ident: 10.1016/j.neures.2011.08.008_bib0245
  article-title: Alpha-lipoic acid as a biological antioxidant
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/0891-5849(95)00017-R
– volume: 11
  start-page: 1135
  year: 2004
  ident: 10.1016/j.neures.2011.08.008_bib0330
  article-title: Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867043365387
– volume: 136
  start-page: 317
  issue: 1
  year: 2002
  ident: 10.1016/j.neures.2011.08.008_bib0010
  article-title: Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
  publication-title: Behav. Brain Res.
  doi: 10.1016/S0166-4328(02)00180-8
– volume: 1498
  start-page: 72
  issue: 1
  year: 2000
  ident: 10.1016/j.neures.2011.08.008_bib0385
  article-title: Nitric oxide induces oxidative stress and apoptosis in neuronal cells
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0167-4889(00)00078-1
– volume: 52
  start-page: 1815
  year: 1996
  ident: 10.1016/j.neures.2011.08.008_bib0295
  article-title: Stimulation of Ca2+ release from rat liver mitochondria by the dithiol reagent alpha-lipoic acid
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/S0006-2952(96)00459-5
– volume: 1802
  start-page: 212
  issue: 1
  year: 2010
  ident: 10.1016/j.neures.2011.08.008_bib0210
  article-title: Mitochondria: a therapeutic target in neurodegeneration
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2009.10.007
– volume: 17
  start-page: 520
  issue: 3
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0255
  article-title: Two caspase-mediated apoptotic pathways induced by rotenone toxicity in cortical neuronal cells
  publication-title: FASEB J.
  doi: 10.1096/fj.02-0653fje
– volume: 1049
  start-page: 147
  year: 2005
  ident: 10.1016/j.neures.2011.08.008_bib0280
  article-title: Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2005.04.051
– volume: 17
  start-page: 207
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0035
  article-title: Lipoic acid: a multifunctional antioxidant
  publication-title: Biofactors
  doi: 10.1002/biof.5520170120
– volume: 1
  start-page: 217
  issue: 2
  year: 2010
  ident: 10.1016/j.neures.2011.08.008_bib0355
  article-title: New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment
  publication-title: EPMA J.
  doi: 10.1007/s13167-010-0019-0
– volume: 21
  start-page: 2226
  year: 2007
  ident: 10.1016/j.neures.2011.08.008_bib0155
  article-title: Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid
  publication-title: FASEB J.
  doi: 10.1096/fj.06-7580com
– volume: 281
  start-page: 10056
  year: 2006
  ident: 10.1016/j.neures.2011.08.008_bib0090
  article-title: Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M512203200
– volume: 14
  start-page: S176
  issue: Suppl. 2
  year: 2008
  ident: 10.1016/j.neures.2011.08.008_bib0380
  article-title: Molecular pathways of programmed cell death in experimental Parkinson's disease
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2008.04.026
– volume: 15
  start-page: S35
  issue: Suppl. 1
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0145
  article-title: Toxic effects of dopamine metabolism in Parkinson's disease
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/S1353-8020(09)70010-0
– volume: 226
  start-page: 1
  issue: 1
  year: 2005
  ident: 10.1016/j.neures.2011.08.008_bib0180
  article-title: Nitric oxide as a modulator of apoptosis
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2004.10.021
– volume: 38
  start-page: 275
  issue: 3
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0230
  article-title: Apoptotic detection methods—from morphology to gene
  publication-title: Prog. Histochem. Cytochem.
  doi: 10.1016/S0079-6336(03)80002-5
– volume: 97
  start-page: 2875
  issue: 6
  year: 2000
  ident: 10.1016/j.neures.2011.08.008_bib0140
  article-title: Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.040556597
– year: 1981
  ident: 10.1016/j.neures.2011.08.008_bib0165
– volume: 9
  start-page: 1
  year: 1997
  ident: 10.1016/j.neures.2011.08.008_bib0135
  article-title: Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization
  publication-title: Biofactors
– volume: 5
  start-page: 62
  issue: 1
  year: 2001
  ident: 10.1016/j.neures.2011.08.008_bib0200
  article-title: A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite
  publication-title: Nitric Oxide
  doi: 10.1006/niox.2000.0319
– volume: 51
  start-page: 9
  issue: 1
  year: 2005
  ident: 10.1016/j.neures.2011.08.008_bib0350
  article-title: Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice
  publication-title: Neurosci. Res.
  doi: 10.1016/j.neures.2004.09.002
– volume: 12
  start-page: 1658
  year: 1996
  ident: 10.1016/j.neures.2011.08.008_bib0275
  article-title: Role of nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrapyridine (MPTP)-induced dopaminergic neurotoxicity
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.12-05-01658.1992
– volume: 70
  start-page: 273
  year: 2006
  ident: 10.1016/j.neures.2011.08.008_bib0290
  article-title: Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD)
  publication-title: J. Neural Transm. Suppl.
– volume: 13
  start-page: 859
  issue: 9
  year: 1988
  ident: 10.1016/j.neures.2011.08.008_bib0375
  article-title: Changes of mitochondrial membrane proteins in rat cerebellum during aging
  publication-title: Neurochem. Res.
  doi: 10.1007/BF00970754
– volume: 84
  start-page: 112
  issue: 1
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0325
  article-title: Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2003.01513.x
– volume: 116
  start-page: 807
  issue: 7
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0360
  article-title: Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats
  publication-title: J. Neural Transm.
  doi: 10.1007/s00702-009-0232-y
– volume: 1802
  start-page: 29
  issue: 1
  year: 2010
  ident: 10.1016/j.neures.2011.08.008_bib0390
  article-title: Mitochondrial dysfunction in Parkinson's disease
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2009.08.013
– volume: 146
  start-page: 1758
  issue: 4
  year: 2007
  ident: 10.1016/j.neures.2011.08.008_bib0045
  article-title: Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2007.04.002
– volume: 24
  start-page: 794
  issue: 5
  year: 2005
  ident: 10.1016/j.neures.2011.08.008_bib0285
  article-title: Efficacy of levo carnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2005.04.005
– volume: 251
  start-page: 98
  issue: 1
  year: 1997
  ident: 10.1016/j.neures.2011.08.008_bib0120
  article-title: Fluorometric and colorimetric detection of caspase activity associated with apoptosis
  publication-title: Anal. Biochem.
  doi: 10.1006/abio.1997.2220
– year: 1996
  ident: 10.1016/j.neures.2011.08.008_bib0070
– volume: 32
  start-page: 1238
  year: 2007
  ident: 10.1016/j.neures.2011.08.008_bib0025
  article-title: Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague–Dawley rats: cellular, molecular and ultrastructural evidences
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-007-9299-8
– volume: 51
  start-page: 35
  issue: 1
  year: 1994
  ident: 10.1016/j.neures.2011.08.008_bib0050
  article-title: An evaluation of the measurement of the activities of complexes I–IV in the respiratory chain of human skeletal muscle mitochondria
  publication-title: Biochem. Med. Metab. Biol.
  doi: 10.1006/bmmb.1994.1004
– volume: 186
  start-page: 235
  issue: 2
  year: 2004
  ident: 10.1016/j.neures.2011.08.008_bib0030
  article-title: Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2003.12.005
– volume: 16
  start-page: 448
  year: 2001
  ident: 10.1016/j.neures.2011.08.008_bib0005
  article-title: Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
  publication-title: Mov. Disord.
  doi: 10.1002/mds.1090
– volume: 37
  start-page: 803
  issue: 6
  year: 2002
  ident: 10.1016/j.neures.2011.08.008_bib0020
  article-title: Effect of dl-alpha-lipoic acid on the status of lipid peroxidation and antioxidant enzymes in various brain regions of aged rats
  publication-title: Exp. Gerontol.
  doi: 10.1016/S0531-5565(02)00015-3
– volume: 153
  start-page: 439
  issue: 2
  year: 2004
  ident: 10.1016/j.neures.2011.08.008_bib0015
  article-title: l-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2003.12.021
– volume: 23
  start-page: 10756
  issue: 34
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0310
  article-title: Mechanism of toxicity in rotenone models of Parkinson's disease
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-34-10756.2003
– volume: 182
  start-page: 84
  year: 2002
  ident: 10.1016/j.neures.2011.08.008_bib0205
  article-title: Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1006/taap.2002.9437
– volume: 50
  start-page: 821
  issue: 6
  year: 2007
  ident: 10.1016/j.neures.2011.08.008_bib0075
  article-title: The effect of subchronic, intermittent l-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2007.02.002
– volume: 34
  start-page: 287
  issue: 3
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0345
  article-title: Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/S0891-5849(02)01327-8
– volume: 1790
  start-page: 1149
  issue: 10
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0305
  article-title: Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2009.07.026
– volume: 959
  start-page: 491
  year: 2002
  ident: 10.1016/j.neures.2011.08.008_bib0125
  article-title: Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-l-carnitine and/or lipoic acid
  publication-title: Ann. N.Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.2002.tb02119.x
– volume: 29
  start-page: 569
  issue: 3
  year: 2004
  ident: 10.1016/j.neures.2011.08.008_bib0370
  article-title: Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease
  publication-title: Neurochem. Res.
  doi: 10.1023/B:NERE.0000014827.94562.4b
– volume: 24
  start-page: 95
  year: 1996
  ident: 10.1016/j.neures.2011.08.008_bib0335
  article-title: Evaluation of the pro-oxidant and antioxidant actions of l-DOPA and dopamine in vitro: implications for Parkinson's disease
  publication-title: Free Radic. Res.
  doi: 10.3109/10715769609088005
– volume: 22
  start-page: 7006
  issue: 16
  year: 2002
  ident: 10.1016/j.neures.2011.08.008_bib0405
  article-title: An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered-synuclein metabolism and oxidative damage
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-16-07006.2002
– volume: 36
  start-page: 348
  issue: 3
  year: 1994
  ident: 10.1016/j.neures.2011.08.008_bib0315
  article-title: Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410360305
– volume: 152
  start-page: 1591
  issue: 9
  year: 2010
  ident: 10.1016/j.neures.2011.08.008_bib0105
  article-title: Anti-apoptotic and neuroprotective effects of alpha-lipoic acid on spinal cord ischemia-reperfusion injury in rabbits
  publication-title: Acta. Neurochir. (Wien)
  doi: 10.1007/s00701-010-0703-9
– volume: 1206
  start-page: 1
  year: 2008
  ident: 10.1016/j.neures.2011.08.008_bib0110
  article-title: Alpha-lipoic acid suppresses 6-hydroxydopamine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2008.01.081
– volume: 87
  start-page: 922
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0095
  article-title: Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2003.02067.x
– volume: 30
  start-page: 245
  year: 1998
  ident: 10.1016/j.neures.2011.08.008_bib0235
  article-title: Alpha-lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury
  publication-title: Drug Metab. Rev.
  doi: 10.3109/03602539808996311
– volume: 6
  start-page: 1480
  issue: 11
  year: 1995
  ident: 10.1016/j.neures.2011.08.008_bib0340
  article-title: Superoxide-dependent depletion of reduced glutathione by l-DOPA and dopamine. Relevance to Parkinson's disease
  publication-title: Neuroreport
  doi: 10.1097/00001756-199507310-00004
– volume: 22
  start-page: 359
  issue: 1–2
  year: 1997
  ident: 10.1016/j.neures.2011.08.008_bib0240
  article-title: Neuroprotection by the metabolic antioxidant alpha-lipoic acid
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/S0891-5849(96)00269-9
– volume: 34
  start-page: 55
  issue: 1
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0195
  article-title: Oxidative and inflammatory pathways in Parkinson's disease
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-008-9656-2
– volume: 86
  start-page: 844
  issue: 23–24
  year: 2010
  ident: 10.1016/j.neures.2011.08.008_bib0055
  article-title: Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2010.03.019
– volume: 1251
  start-page: 80
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0080
  article-title: Distribution study of orally administered lipoic acid in rat brain tissues
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2008.11.025
– volume: 120
  start-page: 623
  year: 2010
  ident: 10.1016/j.neures.2011.08.008_bib0220
  article-title: Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-010-0740-8
– volume: 222
  start-page: 225
  issue: 3
  year: 2006
  ident: 10.1016/j.neures.2011.08.008_bib0270
  article-title: Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells
  publication-title: Toxicology
  doi: 10.1016/j.tox.2006.02.015
– volume: 1619
  start-page: 39
  issue: 1
  year: 2003
  ident: 10.1016/j.neures.2011.08.008_bib0100
  article-title: Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0304-4165(02)00440-3
– volume: 17
  start-page: 55
  year: 1994
  ident: 10.1016/j.neures.2011.08.008_bib0225
  article-title: Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(94)90603-3
– volume: 6
  start-page: 327
  year: 2001
  ident: 10.1016/j.neures.2011.08.008_bib0265
  article-title: Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis
  publication-title: Redox Rep.
  doi: 10.1179/135100001101536472
– volume: 583
  start-page: 3525
  issue: 21
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0300
  article-title: Nitric oxide and dihydrolipoic acid modulate the activity of caspase 3 in HepG2 cells
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2009.10.016
– year: 1999
  ident: 10.1016/j.neures.2011.08.008_bib0060
– volume: 33
  start-page: 305
  year: 1982
  ident: 10.1016/j.neures.2011.08.008_bib0260
  article-title: Parkinson's disease: a disorder due to nigral glutathione deficiency?
  publication-title: Neurosci. Lett
  doi: 10.1016/0304-3940(82)90390-1
– volume: 14
  start-page: 624
  issue: 4
  year: 2009
  ident: 10.1016/j.neures.2011.08.008_bib0115
  article-title: Mitochondria as targets for chemotherapy
  publication-title: Apoptosis
  doi: 10.1007/s10495-009-0323-0
– volume: 67
  start-page: 2282
  year: 1996
  ident: 10.1016/j.neures.2011.08.008_bib0065
  article-title: Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1996.67062282.x
– volume: 10
  start-page: 657
  issue: 3
  year: 2005
  ident: 10.1016/j.neures.2011.08.008_bib0190
  article-title: Evidence for a non-antioxidant, dose-dependent role of alpha-lipoic acid in caspase-3 and ERK2 activation in endothelial cells
  publication-title: Apoptosis
  doi: 10.1007/s10495-005-1901-4
SSID ssj0003943
Score 2.161125
Snippet ► Mitochondria dysfunction-oxidative stress-apoptosis have a role in PD pathogenesis. ► α-Lipoic acid provided early neuroprotection by intervention of this...
The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 387
SubjectTerms Animals
Antiparkinson Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Disease Models, Animal
l-Dopa
Levodopa - pharmacology
Mitochondria - drug effects
Mitochondrial dysfunction
Neurons - drug effects
Neurons - ultrastructure
Neuroprotective Agents - pharmacology
Oxidative stress
Oxidative Stress - drug effects
Parkinson Disease - pathology
Parkinson's disease
Rats
Rotenone - toxicity
Thioctic Acid - pharmacology
Uncoupling Agents - toxicity
α-Lipoic acid
Title Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and l-dopa toxicity
URI https://dx.doi.org/10.1016/j.neures.2011.08.008
https://www.ncbi.nlm.nih.gov/pubmed/21889550
https://www.proquest.com/docview/902675530
Volume 71
WOSCitedRecordID wos000297877000010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1872-8111
  dateEnd: 20210531
  omitProxy: false
  ssIdentifier: ssj0003943
  issn: 0168-0102
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6FFiEuCFp-wk-1B8ol2siJ7bV9DFUQQRBxKCg3a7O7Lq4S20qcKn0sXoEHQOKNmLHXjpNSSg9IlhU5XnuT-XZndvabGUJeW6rn6chymSs9zhzOp2wqhWZWoCRXWriiKAf09aM3HvuTSfC51fpVxcJczLwk8dfrIPuvooZrIGwMnb2FuOuHwgX4DEKHM4gdzv8k-FGTxYi75zBmYY5LVFGfQ10uUZXhlyxdx6rM-11GjLCqIi6mGk-zPMVkJQKOTpbi0JnpTpH-0uR2wIZzjZHDWGgD3nR8Mjx-22OzOEsxC6yMVUeciRgM0A62SNJEszhRK6QcZAKd9GDsV0U6ZkzB-h1M4XUs43xrs3m8ybmJRV4a_rdi30qZNAhzpC4MurXPSCy-ld7dsYA1guiMuk0XB3LsarqI8XpyZNxZW9O212vA02nMwbbR4KU6t8sanlc0Rem0OO_i_6aXm1yulr_RjBUbYEdh1jTGiiF3HpZPCfEpIZb1xPDz_b7nBjDR7g9Gw8mH2jywDZWz-k1VPGdBOrzam-vspevWQ4VddPqQPDALGjoogfiItHRyQA4HicjT-SV9QwuKcbF3c0DufTJMjkPyowlTmkZ0C6b0jzCluzClNUypgINWMKU7MKU1TPFNP78biFKEKDUQpbsQpU2IUoAoLSFKK4g-Jl_eDU9P3jNTT4RJ23dzJvpc2tyeSg1GvdOLBEZ9B1HUt7Qv1FRyHvjC0pgRs4_byZHwIrjRcfvStrWv7CdkD_vxjFCbR1bEI80VLCgCrnzp2JHDp1p53tQVUZvYldRCaZLtY82XWfg3zLQJq1tlZbKZG-73KkCEZhSWhnAIKL-hJa3wE4I-wU1Ckeh0tQwDLEmHtcTa5GmJq7orsBrwA9e1nt-ymy_I_c2ofkn28sVKvyJ35UUeLxdH5I438Y_MKPkN0-YH7w
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intervention+of+mitochondrial+dysfunction-oxidative+stress-dependent+apoptosis+as+a+possible+neuroprotective+mechanism+of+%CE%B1-lipoic+acid+against+rotenone-induced+parkinsonism+and+l-dopa+toxicity&rft.jtitle=Neuroscience+research&rft.au=Abdin%2C+Amany+A.&rft.au=Sarhan%2C+Naglaa+I.&rft.date=2011-12-01&rft.issn=0168-0102&rft.volume=71&rft.issue=4&rft.spage=387&rft.epage=395&rft_id=info:doi/10.1016%2Fj.neures.2011.08.008&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_neures_2011_08_008
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-0102&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-0102&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-0102&client=summon